With the intention to take the company’s growth to a new level, besides tapping the fast growing Indian FMCG market, Emami, beauty and health products maker, is looking at overseas acquisitions in the recent year.

While addressing the company's annual general meeting (AGM) at Kolkata, Emami Ltd Chairman R S Agarwal said, “We are actively considering brand acquisitions abroad for which a blueprint has already been prepared.”

Mr. Agarwal said that during the first quarter of the existing year, Emami had purchased 27.5% equity stake in Zandu Pharmaceuticals as part of its major strategic investment with an aim to be part of management control together with the subsisting promoters.

Moreover, the company’s recent plan is a follow-up to the company's growth strategies.

Mr. Agarwal, however, did not disclose the details of its overseas acquisition plans.

Emami has decided to improve its domestic position by bettering its supply chain and sales in addition to adding new production facility.

He said, “The company has set up a state-of-the-art manufacturing plant in Guwahati at an investment of Rs 40 crore.”

This would be the company’s third major plant after the ones situated at Kolkata and Poducherry.

“The company has engaged Ernst & Young to leverage enhanced value out of our supply chain, sales, distribution and human resources capabilities,” Mr. Agarwal added.